I agree with the thought lines, but there is an international licence issue still unresolved. Why?
GPP are aware or Mr King wiuldnt have mentioned it in the announcement comments. Oversight?
I believe GPP need to explaib the relationship in more detail, along with the intricacies of the licence agreement regarding alternate products to biostimulant.
That line regarding commercial objectives l think has destabilised the SP.
What is the reality?
I would like thank the contribution of all HC posters, its a good discussion. Thanks all.
Ann: Successful OHD Cereal Crop Trials, page-680
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
